LongTerm Evidence Supports Use of SBRT in Prostate Cancer

Long-Term Evidence Supports Use of SBRT in Prostate Cancer

14:41 EST 13 Feb 2019 | OncLive

Stereotactic body radiation therapy has been found to be a safe and effective option for patients with low- and intermediate-risk prostate cancer.

Original Article: Long-Term Evidence Supports Use of SBRT in Prostate Cancer

More From BioPortfolio on "Long-Term Evidence Supports Use of SBRT in Prostate Cancer"